Ozempic® is a registered trademark of Novo Nordisk; Moujarno® is a registered trademark of Eli Lily and Company. Neither drug or company are associated with NexgenMD360.

Limitation of Liability
In no event shall the website owners or its affiliates be liable for any direct, indirect, incidental, special, or consequential damages resulting from the use of the information provided on this site. This includes, but is not limited to, reliance on the information, damages incurred from the use of the products discussed, or any errors or omissions in the content.

By using this website, you hereby consent to our disclaimer and agree to its terms. If you do not agree with this disclaimer, please discontinue the use of our website.